These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
610 related items for PubMed ID: 21519222
1. A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk. Blitz JD, Haile M, Kline R, Franco L, Didehvar S, Pachter HL, Newman E, Bekker A. Am J Ther; 2012 Sep; 19(5):324-9. PubMed ID: 21519222 [Abstract] [Full Text] [Related]
2. Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Bala I, Bharti N, Murugesan S, Gupta R. Minerva Anestesiol; 2014 Jul; 80(7):779-84. PubMed ID: 24280811 [Abstract] [Full Text] [Related]
3. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Candiotti KA, Kovac AL, Melson TI, Clerici G, Joo Gan T, Palonosetron 04-06 Study Group. Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022 [Abstract] [Full Text] [Related]
4. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA. J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735 [Abstract] [Full Text] [Related]
5. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C, Palonosetron 04-07 Study Group. Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021 [Abstract] [Full Text] [Related]
6. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Gan TJ, Candiotti KA, Klein SM, Rodriguez Y, Nielsen KC, White WD, Habib AS. Can J Anaesth; 2009 Nov; 56(11):829-36. PubMed ID: 19730966 [Abstract] [Full Text] [Related]
7. A randomized, double-blind trial evaluating the efficacy of palonosetron with total intravenous anesthesia using propofol and remifentanil for the prevention of postoperative nausea and vomiting after gynecologic surgery. Bang YS, Kim YU, Oh D, Shin EY, Park SK. J Anesth; 2016 Dec; 30(6):935-940. PubMed ID: 27650295 [Abstract] [Full Text] [Related]
8. Effect of palonosetron on postoperative nausea and vomiting in children following dental rehabilitation under general anesthesia. Yildirim MD, Cantekin K. Pediatr Dent; 2014 Dec; 36(1):7E-11E. PubMed ID: 24717698 [Abstract] [Full Text] [Related]
9. Efficacy of palonosetron versus ramosetron on preventing opioid-based analgesia-related nausea and vomiting after lumbar spinal surgery: a prospective, randomized, and double-blind trial. Roh GU, Yang SY, Shim JK, Kwak YL. Spine (Phila Pa 1976); 2014 Apr 20; 39(9):E543-9. PubMed ID: 24480956 [Abstract] [Full Text] [Related]
13. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S, 99-04 Palonosetron Study Group. Cancer; 2003 Dec 01; 98(11):2473-82. PubMed ID: 14635083 [Abstract] [Full Text] [Related]
14. Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting. White PF, Zhao M, Tang J, Wender RH, Yumul R, Sloninsky AV, Naruse R, Kariger R, Cunneen S. Anesth Analg; 2012 Jul 01; 115(1):31-7. PubMed ID: 22504214 [Abstract] [Full Text] [Related]
16. A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period. Hahm TS, Hwang JW, Kim WH, Oh EJ, Kim DK, Choi WJ, Kim YH, Ryu JH, Yoo BH, Yon JH. J Anesth; 2015 Feb 01; 29(1):21-8. PubMed ID: 25037960 [Abstract] [Full Text] [Related]
18. Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial. Choi EK, Kim DG, Jeon Y. Surg Laparosc Endosc Percutan Tech; 2016 Oct 01; 26(5):354-357. PubMed ID: 27636144 [Abstract] [Full Text] [Related]
19. Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial. Hu X, Tan F, Gong L. Drug Des Devel Ther; 2017 Oct 01; 11():1465-1472. PubMed ID: 28553076 [Abstract] [Full Text] [Related]
20. Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: prospective, randomized, and double-blind study. Ryu JH, Chang JE, Kim HR, Hwang JW, Oh AY, Do SH. Int J Surg; 2013 Oct 01; 11(2):183-7. PubMed ID: 23313969 [Abstract] [Full Text] [Related] Page: [Next] [New Search]